Figure 5.
Effects of inactive CORM-3 (iCORM-3, group V) and CORM-3 (group VI) administration on myocardial levels of c-FLIPL and c-FLIPS 24 h later. Upper panels: Representative Western immunoblots showing increased expression of antiapoptotic molecules c-FLIPL and c-FLIPS in the hearts of CORM-3-treated mice compared with iCORM-3-treated mice. Lower panels: Densitometric analysis of c-FLIPL and c-FLIPS signals. Data are means±SEM. *P<0.05 vs. iCORM-3.